Filing Details

Accession Number:
0001140361-14-018764
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-05 17:15:13
Reporting Period:
2014-05-01
Filing Date:
2014-05-05
Accepted Time:
2014-05-05 16:15:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
943819 Resmed Inc RMD Surgical & Medical Instruments & Apparatus (3841) 980152841
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1186102 C Peter Farrell Resmed Inc.
9001 Spectrum Center Boulevard
San Diego CA 92123
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Resmed Common Stock Acquisiton 2014-05-01 25,000 $12.47 329,990 No 4 M Direct
Resmed Common Stock Disposition 2014-05-01 25,000 $49.80 304,990 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Resmed Common Stock ResMed Common Stock Options Disposition 2014-05-01 25,000 $0.00 25,000 $12.47
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
194,204 2006-01-20 2015-01-20 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Resmed Common Stock 200,000 Indirect Peter C. Farrell Grantor Retained Annuity Trust dated December 2012
Resmed Common Stock 200,000 Indirect Peter C. Farrell Grantor Retained Annuity Trust dated March 4, 2014
Footnotes
  1. This transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
  2. Represents date options first became exercisable. Options vest 1/3 per year on the anniversary of the grant.
  3. This transaction was executed in multiple trades at prices ranging from $49.65 to $50.00. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction as effected upon request to the SEC staff, the issuer or the security holder of the issuer.